57 results
8-K
EX-99.2
NTRA
Natera, Inc.
28 Feb 24
Natera Reports Fourth Quarter and Full Year 2023 Financial Results
4:11pm
Panorama screening for 22q is highly differentiated SMART trial enrolled20,000 pregnant women, of which 87.6% had confirmed outcomes 1 Natera Test
8-K
EX-99.2
NTRA
Natera, Inc.
9 Jan 24
Natera Announces Preliminary Fourth Quarter and Full Year 2023 Revenues
7:07am
Not for reproduction or further distribution. Analytical performance Clinical performance SMART trial 1 enrolled20,000 pregnant women, of which
UPLOAD
ncvuae
22 Sep 21
Letter from SEC
12:00am
8-K
EX-99.2
x0yhzaq58
25 Feb 21
Natera Reports Fourth Quarter and Year 2020 Financial Results
4:10pm
8-K
EX-99.2
yd0xf 3fr21ynvfoyal
5 Nov 20
Natera Reports Third Quarter 2020 Financial Results
4:24pm
424B5
u7yd7n
11 Sep 20
Prospectus supplement for primary offering
4:26pm
S-3ASR
23lmdvf54t0at2mjvj5
9 Sep 20
Automatic shelf registration
4:46pm
8-K
EX-99.1
sst44mlp9ieg be8
5 Aug 20
Natera Reports Second Quarter 2020 Financial Results
4:10pm
8-K
EX-99.2
38lwbg9l37gxps7
5 Aug 20
Natera Reports Second Quarter 2020 Financial Results
4:10pm